600285.SH
羚锐制药
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 19.58
+0.20%Margins
Gross margin
80.3%
EBITDA margin
24.9%
EBIT margin
23.2%
Net margin
19.9%
FCF margin
16.3%
21.6%
Return on equity
13.2%
Return on assets
23.4%
Return on invested capital
0.68x
Asset turnover
CNY 704.7M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026